1.Impact of prosthesis-patient mismatch on survival after mitral valve replacement: a systematic review.
Jian-feng ZHANG ; Yi-cheng WU ; Wei-feng SHEN ; Ye KONG
Chinese Medical Journal 2013;126(19):3762-3766
OBJECTIVETo determine whether the prosthesis-patient mismatch has a deleterious impact on survival after mitral valve replacement.
DATA SOURCESA comprehensive literature search of PubMed, Embase, and ScienceDirect was carried out. References and cited papers of relevant articles were also checked.
STUDY SELECTIONAll articles published after January 1980 was initially considered. Non-English and non-human studies, case reports, and reviews were excluded from the initial search. References and cited papers of relevant articles were also checked.
RESULTSA total of 8 retrospective cohort studies were identified for this review. The overall incidence of prosthesis-patient mismatch (<1.3 to <1.2 cm(2)/m(2)) after mitral valve replacement ranged from 3.7% to 85.9% (moderate prosthesis-patient mismatch (0.9 to 1.2 cm(2)/m(2)) in 37.4% to 69.5%, severe prosthesis-patient mismatch (<0.9 cm(2)/m(2)) in 8.7% to 16.4%). Four studies demonstrated an association of prosthesis-patient mismatch with reduced long-term survival, but the other four studies found no significant deleterious impact of prosthesis-patient mismatch after mitral valve replacement. No definite conclusion could be derived from these conflicting results.
CONCLUSIONSCurrent evidence is insufficient to derive a definite conclusion whether mitral prosthesis-patient mismatch affects long-term survival because of the biases and confounding factors that interfere with late clinical outcomes. Goodquality prospective studies are warranted to evaluate the impact of mitral prosthesis-patient mismatch after mitral valve replacement in the future.
Heart Valve Prosthesis ; adverse effects ; Heart Valve Prosthesis Implantation ; mortality ; Humans ; Mitral Valve ; surgery
2.Prediction of short-term mortality after valve surgery.
Liu-Jia-Zi SHAO ; Fu-Shan XUE ; Rui-Juan GUO ; Li ZHENG
Chinese Medical Journal 2019;132(5):624-625
3.Reoperative valve surgery after open-heart valve surgery: a report of 155 cases.
Ni YIN ; Kang ZHOU ; Jianguo HU ; Xinmin ZHOU ; Feng LIU ; Jianming LI ; Bangliang YIN
Journal of Central South University(Medical Sciences) 2011;36(5):435-438
OBJECTIVE:
To summarize the characteristics of reoperative valve surgery after previous open-heart valve surgery.
METHODS:
From 1996 to 2010, 155 patients who underwent reoperative valve surgery, either valve replacement or tricuspid annuloplasty or the repair of perivalvular leakage were included in the study. The reoperative interval was 1-266 (94.82 ± 85.37) months. All surgeries were carried out with extracorporeal circulation under moderated hypothermia. The cardioplegic solution in cold crystal or blood was used if heart beating was stopped during the surgery.
RESULTS:
The total in-hospital mortality was 5.81%, while it was 2.75% from 2005 to 2010. The end-diastolic dimension, size of atrium and ventricles were reduced after the reoperation. Ventricular arrhythmia and low cardiac output were the most frequent complications.
CONCLUSION
The success rate of reoperative valve surgery can be improved by the distinctive therapeutic strategies based on the clinical characteristics and therapy principles obtained from practice experiences.
Adolescent
;
Adult
;
Aged
;
Cardiac Output, Low
;
etiology
;
Cardiopulmonary Bypass
;
Child
;
Female
;
Heart Valve Diseases
;
mortality
;
surgery
;
Heart Valve Prosthesis
;
Heart Valve Prosthesis Implantation
;
adverse effects
;
methods
;
mortality
;
Humans
;
Male
;
Middle Aged
;
Reoperation
;
Tachycardia, Ventricular
;
etiology
;
Young Adult
4.Surgical Experience with Infective Endocarditis and Aortic Root Abscess.
Sak LEE ; Byung Chul CHANG ; Han Ki PARK
Yonsei Medical Journal 2014;55(5):1253-1259
PURPOSE: This study was conducted to evaluate the surgical outcomes of active infective endocarditis with aortic root abscess formation. MATERIALS AND METHODS: Between February 1999 and June 2012, 49 patients underwent surgery for active endocarditis with aortic root abscess. The infected valve was native in 29 patients and prosthetic in 20 patients. The patients' mean age was 50+/-14 years, and 36 patients were male. Surgery was urgent/emergent in 15 patients (31%). The abscess involved the aortic annulus (11), left ventricular outflow tract (18), fibrous trigone (16), and mitral annulus (4). In all patients, wide debridement of abscess and aortic valve replacement with or without patch reconstruction of aortic root or annulus was performed. RESULTS: There were 6 (12%) operative deaths. Causes of early mortality were sepsis (2) and multi-organ failure (4). On postoperative echocardiogram, there was significant improvement of left ventricular dimension (LVEDD, from 58.8+/-11.8 mm to 52.6+/-8.2 mm, p<0.001); however, LV ejection fraction was significantly decreased (from 61.4+/-12.0% to 49.8+/-16.5%, p<0.001). The mean follow-up duration was 68.7+/-40.4 months. There was no late death or recurrent endocarditis during follow up. New York Heart Association functional class significantly improved from 3.2+/-0.7 to 1.2+/-0.4 (p<0.001). Kaplan-Meier estimated survival at 10 years was 87.2%. CONCLUSION: Surgical treatment for active endocarditis with aortic root abscess is still challenging, and was associated with high operative mortality. Nevertheless, long-term survival was excellent with good functional capacity after recovery from the early postoperative period.
Abscess/*surgery
;
Adult
;
Aortic Valve/microbiology/*surgery
;
Debridement
;
Endocarditis/*surgery
;
Female
;
Follow-Up Studies
;
Heart Valve Prosthesis/*microbiology
;
Heart Valve Prosthesis Implantation/*adverse effects/mortality
;
Humans
;
Intraoperative Complications/epidemiology
;
Kaplan-Meier Estimate
;
Male
;
Middle Aged
;
Postoperative Complications/epidemiology
;
Retrospective Studies
5.Short- and Long-Term Results of Triple Valve Surgery: A Single Center Experience.
Sung Ho SHINN ; Sam Sae OH ; Chan Young NA ; Chang Ha LEE ; Hong Gook LIM ; Jae Hyun KIM ; Kil Soo YIE ; Man Jong BAEK ; Dong Seop SONG
Journal of Korean Medical Science 2009;24(5):818-823
Triple valve surgery is usually complex and carries a reported operative mortality of 13% and 10-yr survival of 61%. We examined surgical results based on our hospital's experience. A total of 160 consecutive patients underwent triple valve surgery from 1990 to 2006. The most common aortic and mitral valve disease was rheumatic disease (82%). The most common tricuspid valve disease was functional regurgitation (80%). Seventy-four percent of the patients were in New York Heart Association (NYHA) class III and IV. Univariate and multivariable analyses were performed to identify predictors of early and late survival. Operative mortality was 6.9% (n=11). Univariate factors associated with mortality included old age, preoperative renal failure, postoperative renal failure, pulmonary complications, and stroke. Of them, postoperative renal failure and stroke were associated with mortality on multivariable analysis. Otherwise, neither tricuspid valve replacement nor reoperation were statistically associated with late mortality. Survival at 5 and 10 yr was 87% and 84%, respectively. Ninety-two percent of the patients were in NYHA class I and II at their most recent follow-up. Ten-year freedom from prosthetic valve endocarditis was 97%; from anticoagulation-related hemorrhage, 82%; from thromboembolism, 89%; and from reoperation, 84%. Postoperative renal failure and stroke were significantly related with operative mortality. Triple valve surgery, regardless of reoperation and tricuspid valve replacement, results in acceptable long-term survival.
Adult
;
Aged
;
Anticoagulants/adverse effects/therapeutic use
;
Aortic Valve/*surgery
;
Female
;
Heart Valve Diseases/complications/mortality/*surgery
;
Heart Valve Prosthesis Implantation/*methods
;
Hemorrhage/chemically induced/epidemiology
;
Humans
;
Intraoperative Complications/mortality
;
Kidney Failure/etiology
;
Male
;
Middle Aged
;
Mitral Valve/*surgery
;
Postoperative Complications/mortality
;
Reoperation
;
Risk Factors
;
Severity of Illness Index
;
Stroke/etiology
;
Survival Analysis
;
Thromboembolism/epidemiology
;
Tricuspid Valve/*surgery
6.Long-term results of prosthetic mitral valve replacement with home-made tilting disc valve: a report of 125 cases.
Bao-ren ZHANG ; Zhi-yun XU ; Liang-jian ZOU ; Ju MEI ; Zhi-nong WANG ; Jia-hua HAO
Chinese Journal of Surgery 2003;41(4):253-256
OBJECTIVETo analyze the early and long-term results after mitral valve replacement for rheumatic valvular disease by using home-made tilting disc valve, and the determinant factors involved and subsequent therapies.
METHODSOne hundred and five patients, including 31 patients with rheumatic mitral stenosis, 92 patients with mixed mitral stenosis and regurgitation, and 2 patients with bacterial endocarditis, underwent prosthetic mitral valve replacement with home-made tilting disc valve from September 1978 to June 1982. Three patients had a history of mitral commissurotomy, and 5 patients had concomitant functional tricuspid regurgitation. All patients were operated on under cardiopulmonary bypass with implantation of 25 - 29 mm size home-made tilting disc valve prosthesis. The associated functional tricuspid lesions were treated at the same time with modified DeVega's valvuloplasty or Kays bicuspidate valvuloplasty.
RESULTSEleven patients died during the hospital stay with an early operative mortality of 8.8%. The major causes of the early death were low cardiac output syndrome (4 patients), respiratory failure (2), acute renal failure (2), extrinsic prosthesis dysfunction (1), ventricular arrhythmia (1), and left ventricular rupture (1). Ninety-eight survivors were followed up (total 1,162.2 years) for mean duration of 12.8 years. Eighty-nine patients (78%) survived over 10 years after operation, 58 (51%) over 15 years, and 55 (48%) over 20 years. There were 16 late deaths due to heart failure, anticoagulation related bleeding, thromboembolism and recurrence of rheumatic fever. The survival rates at 10 and 20 years were 82.3% and 51.1% respectively. Among the patients who survived over 20 years, 37 patients had the cardiac functional status returned to Class II, 13 Class III, and Class IV.
CONCLUSIONSSevere post-rheumatic valve deformity may occur in younger patients in China. Long-acting penicillin regimen given for 3 - 5 years for the prevention of rheumatic fever relapse is advocated. A low intensity anticoagulant regimen after mitral valve replacement is advisable in lowering the incidence of anticoagulant related bleeding, while optimizing sufficient protection against thromboembolic complication. Proper operative timing (e.g. when the patient is in sinus rhythm and in NYHA functional class II) is of great importance in achieving satisfied long-term results.
Adolescent ; Adult ; Anticoagulants ; administration & dosage ; adverse effects ; therapeutic use ; Female ; Follow-Up Studies ; Heart Valve Diseases ; etiology ; surgery ; Heart Valve Prosthesis Implantation ; instrumentation ; methods ; mortality ; Hemorrhage ; chemically induced ; prevention & control ; Humans ; Male ; Middle Aged ; Mitral Valve ; surgery ; Postoperative Complications ; prevention & control ; Retrospective Studies ; Rheumatic Heart Disease ; complications ; Secondary Prevention ; Survival Analysis ; Survival Rate ; Time Factors ; Treatment Outcome ; Young Adult